Physician

Thomas I. Margolis, MD

According to 2025 Medicare claims, Thomas Margolis, MD (NPI: 1730153461) practices ophthalmology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is RETINAL & OPHTHALMIC CONSULTANTS, P.C. (NPI: 1750356481; TIN: 223146260) and primary practice location at 08225-1827.

Margolis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 871 traditional Medicare patients, billed 53,580 HCPCS/CPT codes, and received $2,854,379 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 382 prescription claims across 92 beneficiaries totaling $41,374 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 8 records totaling $135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $21,684 to $41,374. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,358	12,565	$3,129,588
2016	1,376	13,169	$3,272,235
2017	1,243	12,444	$3,220,006
2018	1,160	13,015	$3,405,488
2019	1,050	11,658	$3,263,281
2020	907	10,023	$2,717,915
2021	946	9,721	$2,656,652
2022	899	17,273	$2,582,793
2023	886	43,732	$2,571,132
2024	871	53,580	$2,854,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	87	269	$21,684
2016	92	252	$25,218
2017	83	241	$20,822
2018	95	310	$27,622
2019	101	429	$38,915
2020	96	384	$43,318
2021	83	347	$33,298
2022	108	387	$37,591
2023	80	315	$36,985
2024	92	382	$41,374

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	264	1,301	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	570	703	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	241	671	$75
92134	Imaging of retina	802	1,935	$34
J2777	Injection, faricimab-svoa, 0.1 mg	145	41,340	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	54	1,461	$8,077
Prolensa	Bromfenac Sodium	22	704	$7,694
Prednisolone Acetate	Prednisolone Acetate	91	4,377	$4,031
Loteprednol Etabonate	Loteprednol Etabonate	13	638	$3,146
Travoprost	Travoprost	11	275	$1,105

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$135	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas I. Margolis, MD?

Tedicare shows public-source Medicare data for Thomas I. Margolis, MD (NPI 1730153461), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas I. Margolis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas I. Margolis, MD?

Thomas I. Margolis, MD is linked to RETINAL & OPHTHALMIC CONSULTANTS, P.C. (billing NPI 1750356481) in the available physician profile data.

Does Thomas I. Margolis, MD have Open Payments data?

Thomas I. Margolis, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.